Table of Contents Author Guidelines Submit a Manuscript
Retracted

The paper has been retracted upon the authors’ request, as the routine hospital laboratory evaluation protocol used varied from recommended best practice study design. Although this protocol established the fact that GlucoRx Nexus Voice system was clinically accurate, it could not be used to make valid analytical accuracy statements relating to ISO 15197 standards. GlucoRx Nexus meters are now the formulary choice in the area.

View the full Retraction here.

References

  1. M. Khan, K. Broadbent, M. Morris, D. Ewins, and F. Joseph, “System accuracy evaluation of the glucoRx nexus voice TD-4280 blood glucose monitoring system,” Disease Markers, vol. 2014, Article ID 602586, 8 pages, 2014.
Retraction
Letter to the Editor
Disease Markers
Volume 2014, Article ID 602586, 8 pages
http://dx.doi.org/10.1155/2014/602586
Research Article

System Accuracy Evaluation of the GlucoRx Nexus Voice TD-4280 Blood Glucose Monitoring System

1Department of Diabetes & Endocrinology, Countess of Chester Hospital NHS Foundation Trust, Chester CH2 1UL, UK
2Department of Clinical Sciences & Nutrition, University of Chester, Chester CH1 4BJ, UK

Received 7 June 2014; Accepted 15 September 2014; Published 13 October 2014

Academic Editor: Vincent Sapin

Copyright © 2014 Muhammad Khan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Smyth and A. Heron, “Diabetes and obesity: the twin epidemics,” Nature Medicine, vol. 12, no. 1, pp. 75–80, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. R. P. Robertson, D. M. Kendall, and E. R. Seaquist, “Diabetes: strategies to prevent the type 2 diabetes mellitus epidemic,” Nature Reviews Endocrinology, vol. 6, no. 3, pp. 128–129, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Chen, D. J. Magliano, and P. Z. Zimmet, “The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives,” Nature Reviews Endocrinology, vol. 8, no. 4, pp. 228–236, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Z. Zimmet, D. J. Magliano, W. H. Herman, and J. E. Shaw, “Diabetes: a 21st century challenge,” The Lancet Diabetes and Endocrinology, vol. 2, no. 1, pp. 56–64, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Zimmet, K. G. Alberti, and J. Shaw, “Global and societal implications of the diabetes epidemic,” Nature, vol. 414, no. 6865, pp. 782–787, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. International Diabetes Federation, “IDF Diabetes Atlas,” 2013, http://www.idf.org/sites/default/files/EN_6E_Atlas_Full_0.pdf.
  7. World Health Organisation, Global Status Report on Noncommunicable Diseases [Online], 2011, http://www.who.int/nmh/publications/ncd_report_full_en.pdf.
  8. N. Hex, C. Bartlett, D. Wright, M. Taylor, and D. Varley, “Estimating the current and future costs of Type1 and Type2 diabetes in the UK, including direct health costs and indirect societal and productivity costs,” Diabetic Medicine, vol. 29, no. 7, pp. 855–862, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. London School of Economics, Diabetes Expenditure, Burden of Disease and Management in 5 EU Countries, London School of Economics, London, UK, 2012, http://www.lse.ac.uk/LSEHealthAndSocialCare/research/LSEHealth/MTRG/LSEDiabetesReport26Jan2012.pdf.
  10. American Diabetes Association, “Economic costs of diabetes in the U.S. in 2012,” Diabetes Care, vol. 36, no. 4, pp. 1033–1046, 2013. View at Publisher · View at Google Scholar
  11. L. Blonde and A. J. Karter, “Current evidence regarding the value of self-monitored blood glucose testing,” The American Journal of Medicine, vol. 118, no. 9, pp. 20S–26S, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Li, P. Zhang, L. E. Barker, F. M. Chowdhury, and X. Zhang, “Cost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review,” Diabetes Care, vol. 33, no. 8, pp. 1872–1894, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Ziegler, B. Heidtmann, D. Hilgard, S. Hofer, J. Rosenbauer, and R. Holl, “Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes,” Pediatric Diabetes, vol. 12, no. 1, pp. 11–17, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. W. H. Polonsky, L. Fisher, C. H. Schikman et al., “Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the Structured Testing Program study,” Diabetes Care, vol. 34, no. 2, pp. 262–267, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. M. M. Austin, L. Haas, T. Johnson et al., “Self-monitoring of blood glucose: benefits and utilization,” Diabetes Educator, vol. 32, no. 6, pp. 835–847, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. The Diabetes Control and Complications Trial Research Group, “The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus,” The New England Journal of Medicine, vol. 329, pp. 977–986, 1993. View at Google Scholar
  17. UK Prospective Diabetes Study Group, “Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients w ith type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group,” The Lancet, vol. 352, pp. 837–853, 1998. View at Google Scholar
  18. D. E. Goldstein, R. R. Little, R. A. Lorenz, J. I. Malone, D. M. Nathan, and C. M. Peterson, “Tests of glycemia in diabetes,” Diabetes Care, vol. 26, supplement 1, pp. S106–S108, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. National Institute for Health and Clinical Excellence, “Type 2 diabetes: the management of type 2 diabetes,” 2009, http://www.nice.org.uk/nicemedia/pdf/CG87NICEGuideline.pdf.
  20. J. L. Parkes, S. L. Slatin, S. Pardo, and B. H. Ginsberg, “A new consensus error grid to evaluate the clinical significance of inaccuracies in the measurement of blood glucose,” Diabetes Care, vol. 23, no. 8, pp. 1143–1148, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. ISO 15197, “In vitro diagnostic test systems—requirements for blood glucose monitoring systems for self-testing in managing diabetes mellitus,” 2013, http://www.iso.org/iso/catalogue_detail?csnumber=26309.
  22. G. Freckmann, A. Baumstark, N. Jendrike et al., “System accuracy evaluation of 27 blood glucose monitoring systems according to DIN en ISO 15197,” Diabetes Technology and Therapeutics, vol. 12, no. 3, pp. 221–231, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Freckmann, C. Schmid, A. Baumstark, S. Pleus, M. Link, and C. Haug, “System accuracy evaluation of 43 blood glucose monitoring systems for self-monitoring of blood glucose according to DIN en ISO 15197,” Journal of Diabetes Science and Technology, vol. 6, no. 5, pp. 1060–1075, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. J. M. Bland and D. G. Altman, “Statistical methods for assessing agreement between two methods of clinical measurement,” The Lancet, vol. 1, no. 8476, pp. 307–310, 1986. View at Google Scholar · View at Scopus
  25. A. Pfützner, D. C. Klonoff, S. Pardo, and J. L. Parkes, “Technical aspects of the Parkes error grid,” Journal of Diabetes Science and Technology, vol. 7, no. 5, pp. 1275–1281, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Frank, J. F. Wallace, S. Pardo, and J. L. Parkes, “Performance of the CONTOUR TS blood glucose monitoring system,” Journal of Diabetes Science and Technology, vol. 5, no. 1, pp. 198–205, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. C.-Y. Kuo, C.-T. Hsu, C.-S. Ho, T.-E. Su, M.-H. Wu, and C.-J. Wang, “Accuracy and precision evaluation of seven self-monitoring blood glucose systems,” Diabetes Technology and Therapeutics, vol. 13, no. 5, pp. 596–600, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Tack, H. Pohlmeier, T. Behnke et al., “Accuracy evaluation of five blood glucose monitoring systems obtained from the pharmacy: a European multicenter study with 453 subjects,” Diabetes Technology and Therapeutics, vol. 14, no. 4, pp. 330–337, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Pftzner, M. Mitri, P. B. Musholt et al., “Clinical assessment of the accuracy of blood glucose measurement devices,” Current Medical Research and Opinion, vol. 28, no. 4, pp. 525–531, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. D. C. Klonoff, “The need for separate performance goals for glucose sensors in the hypoglycemic, normoglycemic, and hyperglycemic ranges,” Diabetes Care, vol. 27, no. 3, pp. 834–836, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Heinemann, V. Lodwig, and G. Freckmann, “Accuracy in blood glucose measurement: what will a tightening of requirements yield?” Journal of Diabetes Science and Technology, vol. 6, no. 2, pp. 435–443, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Rebel, M. A. Rice, and B. G. Fahy, “The accuracy of point-of-care glucose measurements,” Journal of Diabetes Science and Technology, vol. 6, no. 2, pp. 396–411, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. B. H. Ginsberg, “Factors affecting blood glucose monitoring: sources of errors in measurement,” Journal of Diabetes Science and Technology, vol. 3, no. 4, pp. 903–913, 2009. View at Publisher · View at Google Scholar · View at Scopus